Dual Energy CT vs Standard Triple Phase CT-A Randomised Control Trial

To compare SBDECT with standard Triple Phase Multi-Detector CT (TPMDCT) in renal mass evaluation in terms of appropriateness of treatment received after diagnosis. To determine SBDECT diagnostic accuracy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Renal Cell Carcinoma AML Adenocarcinoma Carcinoma Carcinoma, Renal Cell Carcinoma, Transitional Cell Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Kidney Neoplasms Male Urogenital Diseases Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Glandular and Epithelial Renal Cysts Transitional Cell Carcinoma Urogenital Diseases Urogenital Neoplasms Urologic Diseases Urologic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

All India Institute of Medical Sciences

New Delhi, National Capital Territory of Delhi, 110029, India

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with suspected renal masses needing further evaluation with a contrast enhanced CT scan
Patients who are referred for CT Urography

Exclusion criteria

Patients not willing to participate in the study
Age <18 yrs
Pregnant females
Patients with previous h/o serious allergic reactions or Contrast allergy
Impaired renal function (estimated GFR<45mL/min/mm2)
Sonographically proven benign renal mass needing no further evaluation

Treatment and study plan

Standard multiphase CT

Other

split bolus Dual energy CT

Other

Primary outcomes

Appropriateness of the treatment recieved

Time frame: 1 year

Sponsors and collaborators

Lead sponsor

All India Institute of Medical Sciences

Other

Registry information

Official study title

Role of Split Bolus Dual Energy Single Acquisition CT in Evaluation of Urological Diseases of the Upper Urinary Tract.

Important dates

Study start: 2014
Primary completion: 2016
Study completion: 2016
First posted: Jun 10, 2014
Registry last updated: Apr 27, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed